Home Knowledge Hub A new statistical method to assess in vitro bioequivalence of nasal products A new statistical method to assess in vitro bioequivalence of nasal products 05/06/2021 Share this article: Facebook Twitter LinkedIn
2024 Corporate Plants Nemera’s Engineering Expertise – Standing Firmly at the Crossroads of the Company’s Value Chain 12/09/2024 Read our 2023 ESG report to know more where we stand today on sustainability, our strategic priorities and objectives Continue Reading
2023 2024 ESG Our 2023 ESG report is published! 05/06/2024 Read our 2023 ESG report to know more where we stand today on sustainability, our strategic priorities and objectives Continue Reading
2023 ESG The Gender Equality Index at Nemera – Year 2023 28/02/2024 The Index, is calculated from 4 to 5 indicators depending on whether the company has less or more than 250 employees and takes into account Continue Reading